Skip to main content
OpenTrials

Clinical trial condition

Recurrent Breast Cancer

Explore clinical trials studying Recurrent Breast Cancer. Study availability and eligibility vary by location and protocol.

99 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Breast Cancer trial results

Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

NCT06369285

Conditions
Breast Diseases, Breast Neoplasms, Hormone Receptor Positive HER-2 Negative Breast Cancer, +6 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • MemorialCare Orange Coast Medical Center Fountain Valley, California, United States
View all 53 locations
View Trial Details
Recruiting

PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

NCT04360941

Conditions
Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +10 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Hope Clinical Trials Cancer Centre Leicester, United Kingdom
View Trial Details
Active, not recruiting

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

NCT01953588

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 860 locations
View Trial Details
Completed

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

NCT01730833

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope- South Pasadena Cancer Center South Pasadena, California, United States
View Trial Details

Related conditions